MAIA Biotechnology, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Convertible Notes Payable - Additional Information (Details)

Convertible Notes Payable - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Aug. 01, 2022
Short-Term Debt [Line Items]
Interest expense	$ 57	$ 6,863
Warrants exercise price, per share			$ 6.25

- Definition

Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.

+ References + Details